Virtu Financial’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Virtu Financial’s Portfolio MLNT Stock Details MLNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$8K	Buy	+15,331	New	+$37.2K	﹤0.01%	1380

Other funds holding MLNT

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CCM

Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Virtu Financial's MLNT Position: Q4 2019 in Review

Virtu Financial opened a new position in Melinta Therapeutics, Inc. Common Stock (MLNT) in Q4 2019: 15,331 shares worth $8K. The stake represents ﹤0.01% of the portfolio and ranks #1380 among its holdings.

37 funds tracked by Wall St. Rank hold MLNT as of Q4 2019.

Virtu Financial held 15,331 shares of Melinta Therapeutics, Inc. Common Stock worth $8K as of Q4 2019.
Melinta Therapeutics, Inc. Common Stock was a new Virtu Financial position in Q4 2019.
Melinta Therapeutics, Inc. Common Stock made up ﹤0.01% of Virtu Financial's portfolio in Q4 2019, its #1380 holding.
37 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Virtu Financial's 13F filing for Q4 2019, filed 4 Feb 2020.